retatrutide nejm 2023 obesity trial ly3437943 produces up to 30.3% weight loss in Phase 3 A study of Lilly's retatrutide

However, Eli Lilly has shown with tirzepatide (Mounjaro/Zepbound) a willingness to price competitively in the GLP-1 market

the blend is preclinical and not approved for human use

While the benefits of GLP-1 agonists like Semaglutide and Tirzepatide for PCOS-related weight loss are promising, its important to approach them with a balanced perspective

L- -

But there is less flexibility for employers to do so if they have fewer than 100 employees and are fully insured, as opposed to self-insured. (Blue Cross and Point32Health offer both types of plans more on this below.) How does a fully insured plan work

Semaglutide for Weight Loss (SURMOUNT-5)